28 studies found for:    " January 24, 2007":" February 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed
Has Results
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
2 Completed Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial
Condition: HIV Infections
Intervention: Behavioral: Nutritional
3 Completed Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
Conditions: HIV Infections;   Substance Abuse;   Sexually Transmitted Diseases
Interventions: Behavioral: EDGE counseling, no maintenance;   Behavioral: EDGE counseling, plus maintenance;   Behavioral: Attention control
4 Completed Long Term Treatment Interruptions
Conditions: HIV Infections;   AIDS
Interventions: Other: STI;   Drug: stable HAART
5 Completed Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults
Condition: HIV Infections
Interventions: Biological: EP-1233;   Biological: MVA-mBN32
6 Recruiting Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
Condition: HIV Infections
Intervention:
7 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
8 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
9 Active, not recruiting Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
Conditions: Anus Neoplasms;   HIV Infections
Intervention: Procedure: Argon Plasma Coagulation
10 Completed Effects of Anti-HIV Therapy on Nervous System Function
Condition: HIV Infections
Intervention:
11 Completed Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
Condition: HIV Infections
Intervention:
12 Completed Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV
Condition: HIV Infections
Interventions: Drug: zidovudine;   Drug: amdoxovir;   Procedure: pharmacokinetic sampling
13 Terminated Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.
Conditions: HIV Infections;   Lymphoma, Non-Hodgkin
Intervention: Procedure: autologous peripheral blood cell transplantation
14 Completed Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
Condition: HIV Infections
Interventions: Drug: Placebo;   Drug: Aprepitant
15 Completed Lopinavir Capsules to Kaletra or Invirase Tablets
Condition: HIV Infections
Interventions: Drug: Saquinavir (Invirase®);   Drug: Lopinavir/ritonavir (Kaletra®)
16 Unknown  A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
Condition: HIV Infections
Intervention:
17 Completed Study of Pharmacokinetics in HIV-infected Women
Condition: HIV Infections
Intervention: Drug: antiretroviral treatment
18 Unknown  Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
Conditions: HIV Infections;   Tuberculous Meningitis
Intervention: Drug: Combivir and efavirenz
19 Completed Pharmacogenetics of Antiretroviral Drugs
Condition: HIV Infections
Intervention:
20 Completed Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring
Conditions: Acquired Immunodeficiency Syndrome;   Resistance
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
Indicates status has not been verified in more than two years